Table 3.
Covariate | Odds ratio | 95% confidence interval | P |
---|---|---|---|
Age (years)a | |||
65–74 | 1.491 | 1.128–1.972 | 0.0050 |
≥74 | 2.256 | 1.763–2.888 | <0.0001 |
Maleb | 0.802 | 0.681–0.945 | 0.0083 |
Health insurancec | |||
No health insurance | 1.527 | 1.176–1.983 | 0.0015 |
Medicaid | 1.302 | 0.993–1.707 | 0.7613 |
Medicare | 1.666 | 1.324–2.097 | 0.0259 |
Smoking | 0.603 | 0.439–0.827 | 0.0017 |
Alcohol abuse | 1.165 | 0.873–1.556 | 0.2993 |
Obesity | 0.582 | 0.444–0.762 | <0.0001 |
Chronic comorbidity | |||
Myocardial infarction | 1.414 | 1.009–1.981 | 0.0441 |
Congestive heart failure | 1.695 | 1.387–2.071 | <0.0001 |
Dementia | 1.485 | 0.725–3.041 | 0.2798 |
Diabetes | 0.750 | 0.623–0.903 | 0.0023 |
Chronic renal disease | 1.738 | 1.424–2.121 | <0.0001 |
Chronic liver disease | 3.204 | 2.336–4.394 | <0.0001 |
Malignancy | 2.577 | 1.934–3.434 | <0.0001 |
Cerebrovascular disease | 1.128 | 0.776–1.639 | 0.5288 |
HIV infectiond | 1.524 | 0.721–3.225 | 0.2700 |
Teaching hospital | 1.208 | 1.014–1.438 | 0.0344 |
Type of organ failure | |||
Respiratory | 3.392 | 2.679–4.294 | <0.0001 |
Type of organ failure | |||
Cardiovascular | 2.820 | 2.336–3.406 | <0.0001 |
Renal | 1.308 | 1.088–1.573 | 0.0042 |
Hepatic | 0.797 | 0.492–1.290 | 0.3561 |
Hematological | 1.597 | 1.288–1.980 | <0.0001 |
Metabolic | 1.553 | 1.250–1.930 | <0.0001 |
Neurological | 1.661 | 0.800–3.451 | 0.1735 |
Number of organ failurese | |||
1 organ failure | 3.148 | 2.475–4.005 | 0.0001 |
2 organ failures | 6.650 | 5.163–8.565 | <0.0001 |
≥3 organ failures | 13.500 | 10.471–17.406 | <0.0001 |
Life-support interventions | |||
Mechanical ventilation | 1.851 | 1.467–2.335 | <0.0001 |
Central venous catheterization | 0.742 | 0.620–0.888 | 0.0011 |
Hemodialysis | 1.337 | 1.020–1.754 | 0.0354 |
Hyperbaric oxygen | 0.114 | 0.026–0.495 | 0.0037 |
aAge < 65 years was used as referent; bfemale gender was used as referent; gender was masked in 1214 hospitalizations. The model to examine the role of gender was restricted to hospitalizations with available gender designation (n = 10,958); cprivate insurance was used as referent; dhuman immunodeficiency virus/acquired immunodeficiency syndrome; ehospitalizations with zero organ failures were used as referent.